Sponsor or institution
Clinical trials and research at OBI Pharma, Inc
As of November 12, 2026, Find a Trial lists 2 clinical trials run by OBI Pharma, Inc that are recruiting, at sites in 2 countries (most in Taiwan (2), United States (1)). By phase: Phase 1/2 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
OBI-902 for people with advanced solid tumors
This trial tests OBI-902 to see if it is safe and can shrink tumors in adults with advanced solid cancers who have tried or cannot have standard treatments.
-
Evaluating OBI-833/OBI-821 with Erlotinib for Lung Cancer
This study is testing if adding two new treatments, OBI-833 and OBI-821, to the standard lung cancer drug erlotinib can help people with a specific type of lung cancer feel better and live longer.
Quick answers
How many clinical trials run by OBI Pharma, Inc are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Taiwan (2 trials), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.